作者
Roberto Silva Costa,Werbson Lima Guaraná,Braziliano Júnior,Laís Quintiliano Pedroza,Luís Inês,Paula Sandrin‐Garcia,Thiago Sotero Fragoso
摘要
PV102 / #625 Poster Topic: AS12 - Genetics, Epigenetics, Transcriptomics Background/Purpose Interferon Pathways studies have highlighted the role of type I interferons, especially interferon-alpha (IFN-α), in driving inflammatory pathways in lupus. Elevated levels of IFN-α are often associated with disease activity. However, few studies have been performed to clarify the role of IFN-α in ocular involvement, including dry eye and retinal changes in Systemic Erythematosus Lupus (SLE). We aimed to assess the association between IFN-α genes signature and ophthalmological involvement in SLE patients. Methods We evaluated patients aged 18 years or older at the Rheumatology unit of Professor Alberto Antunes University Hospital – Federal University of Alagoas, Brazil, who fulfilled 2019 EULAR/ACR criteria for SLE and attended medical routine consultation. A retinal specialist performed Clinical Ophthalmologic evaluation. In this analysis, we excluded eye problems related to treatment, such as cataracts or Hydroxychloroquine retinopathy. We utilized SLEDAI-2K to measure disease activity and blood samples were obtained from patients on the same day of clinical evaluation. Isolation of mononuclear cells (PBMC) and RNA extraction were performed, followed by cDNA synthesis. The expression of the IFI27, IFI44L, IFIT1, ISG15, RSAD2, and SIGLEC1 genes was performed via real-time PCR, using the reference genes RPLP0 and EEF1A1 for normalization. The median of the normalized relative quantity (NRQ) of the genes of each patient was used to calculate the fold change (FC) of the “Interferon Score.” Statistical analysis was performed with GraphPad Prism® 8.0, using the Mann-Whitney test for group comparisons and the Spearman test for correlation analysis. Results The group sample consisted of 38 SLE patients. We identified SLE eye involvement in 57.89% (22/38). Of these, 36.6% (8/22) had lupus retinopathy, 68% (14/22) dry eye, and 18% (4/22) Lupus choroidopathy. 65% of the patients had active disease measured by SLEDAI-2K. We verified higher expression levels of IFN-a gene signature in SLE patients with eye involvement (FC= 2,52 ±1,96; p=0,0027). Conclusions Upregulation of Interferon-alpha genes was observed in SLE patients with ocular involvement, supporting the hypothesis that Interferon-alpha may be an important factor in the inflammatory ophthalmic conditions associated with SLE.